유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)
관세와 무역 장벽의 출현, 정책 변화 등으로 올해 유럽 바이오기업들의 자금조달이 쉽지 않은 상황이라는 In Vivo 기사를 요약한 내용입니다. https://insights.citeline.com/in-vivo/market-intelligence/the-360-degr...
Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and ...
Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone
The European Commission has put forward a series of proposals designed to simplify European Union sustainability rules and boost the region’s competit...
Scrip's Five Must-Know Things - 16 June 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 June 2025. In this episode: breaking down big pharma’s...
Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Francesca Bruce, Senior Editor Cathy Kelly and Editor-in-Chief Nielsen Hobbs consider Europ...
Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)
The 14 July entry deadline for the Citeline Japan Awards 2025 in Tokyo on 21 October is fast approaching! Join Ian Haydock and Lisa Takagi in this bil...
Through Thick and Thin: Funding the Future with Grit
In a tough market, biotech is racing to change the rules. This episode reveals how AI, real-world data, and strategic partnerships are reshaping drug ...
First Sparks: Falling for Innovation in a Harsh Market
In this first episode of the series, small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface,...
Scrip's Five Must-Know Things - 9 June 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 June 2025. In this episode: Sanofi’s Blueprint buy; Ast...
Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss why ...